Patamostat
Patamostat (E-3123) is a potent protease inhibitor. Patamostat potently inhibits trypsin, plasmin and thrombin with IC50s of 39 nM, 950 nM and 1.9 μM, respectively. Patamostat may possess suppressing effects on pathogenesis and development of acute pancreatitis[1][2].
Product Specifications
CAS Number
[114568-26-2]
Product Name Alternative
E-3123
UNSPSC
12352005
Target
Ser/Thr Protease
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/patamostat.html
Concentration
10mM
Purity
98.13
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(OC1=CC=C(SCCN2C(CCC2=O)=O)C=C1)C3=CC=C(NC(N)=N)C=C3
Molecular Formula
C20H20N4O4S
Molecular Weight
412.46
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
CXCL5 (Chemokine (C-X-C Motif) Ligand 5, Epithelial Derived Neutrophil Activating Peptide 78, Epithelial Derived Neutrophil Activating Protein 78, ENA78, ENA-78, Neutrophil Activating Peptide ENA-78, Small Inducible Cytokine Subfamily B Member 5, Small In
CXCL5 (Chemokine (C-X-C Motif) Ligand 5, Epithelial Derived Neutrophil Activating Peptide 78, Epithelial Derived Neutrophil Activating Protein 78, ENA78, ENA-78, Neutrophil Activating Peptide ENA-78, Small Inducible Cytokine Subfamily B Member 5, Small In
